Treatment-related morbidity in prostate cancer: A comparison of 3-dimensional conformal radiation therapy with and without image guidance using implanted fiducial markers

International Journal of Radiation Oncology Biology Physics

Volumn 85, Issue 4, 2013, Pages 1018-1023

  Singh, Jasmeet ^a   Greer, Peter B ^b   White, Martin A ^c   Parker, Joel ^a   Patterson, Jackie ^a   Tang, Colin I ^a,c   Capp, Anne ^a,c   Wratten, Christopher ^a,c   Denham, James W ^a,c  

^a CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CONFORMAL RADIATION THERAPY; DOSE-VOLUME HISTOGRAMS; IMAGE-GUIDED RADIATION THERAPY; LOGISTIC REGRESSION MODELS; METHODS AND MATERIALS; MULTIVARIABLE ANALYSIS; PROSTATE CANCERS; TREATMENT-RELATED MORBIDITIES;

DISEASES; LOGISTICS; MAGNETIC RESONANCE; REGRESSION ANALYSIS; TUMORS;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; DEFECATION HABIT; DIARRHEA; FIDUCIAL MARKER; FOLLOW UP; HUMAN; IMAGE ANALYSIS; IMAGE GUIDED RADIOTHERAPY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; RADIATION DOSE; RECTUM DISEASE; THREE DIMENSIONAL IMAGING; URINARY DYSFUNCTION; URINARY URGENCY;

AGED; AGED, 80 AND OVER; DIAGNOSTIC SELF EVALUATION; DIARRHEA; FIDUCIAL MARKERS; GOLD; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGANS AT RISK; PAIN; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUESTIONNAIRES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, IMAGE-GUIDED; RECTUM; REGRESSION ANALYSIS; TUMOR BURDEN; URINARY BLADDER; URINATION DISORDERS;

EID: 84875219425     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.07.2376     Document Type: Article

References (22)

1. D.A. Kuban, S.L. Tucker, and L. Dong Long term results of the M.D Anderson randomized dose-escalation trial for prostate cancer Int J Radiat Oncol Biol Phys 70 2008 67 74
2. D.P. Dearnaley, M.R. Sydes, and J.D. Graham Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomized controlled trial Lancet Oncol 8 2007 475 487
3. S.T. Peeters, W.D. Heemsbergen, and P.C. Koper Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy J Clin Oncol 24 2006 1990 1996
4. M.R. Storey, A. Pollack, and G. Zagars Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomised trial Int J Radiat Oncol Biol Phys 48 2000 635 642
5. M.J. Zelefsky, Y. Yamada, and M.A. Kollmeier Long-term outcome following three-dimensional conformal/intensity-modulated external-beam radiotherapy for clinical stage T3 prostate cancer Eur Urol 53 2008 1172 1179
6. A. Al-Mamgani, W.D. Heemsbergen, and S.T. Peeters Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer Int J Radiat Oncol Biol Phys 73 2009 685 691
7. W.D. Heemsbergen, M.S. Hoogeman, and M.G. Witte Increased risk of biochemical and clinical failure for prostate patients with a large rectum at radiotherapy planning: Results from the Dutch Trial of 68 Gy versus 78 Gy Int J Radiat Oncol Biol Phys 67 2007 1418 1424
8. J.M. Crook, Y. Raymond, and D. Salhani Prostate motion during standard radiotherapy as assessed by fiducial markers Radiother Oncol 37 1995 35 42
9. M.S. Litwin, R.D. Hays, and A. Fink Quality-of-life outcomes in men treated for localized prostate cancer JAMA 273 1995 129 135
10. D. Christie, J. Denham, and A. Steigler Delayed rectal and urinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivation Radiother Oncol 77 2005 117 125
11. C. Fiorino, G. Fellin, and T. Rancati Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: Preliminary results of a multicenter prospective study Int J Radiat Oncol Biol Phys 70 2008 1130 1137
12. J.A. Hatton, P.B. Greer, and C. Tang Does the planning dose-volume histogram represent treatment doses in image-guided prostate radiation therapy? Assessment with cone-beam computerized tomography scans Radiother Oncol 98 2011 162 168
13. N.S. Anderson, J.B. Yu, and R.E. Peschel A significant decrease in rectal volume and diameter during prostate IMRT Radiother Oncol 98 2011 187 191
14. A. Jackson, M.W. Skwarchuk, and M.J. Zelefsky Late rectal bleeding after conformal radiotherapy of prostate cancer: II. Volume effects and dose-volume histograms Int J Radiat Oncol Biol Phys 49 2001 685 698
15. C. Cozzarini, C. Fiorino, and G.L. Ceresoli Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2 Gy) Int J Radiat Oncol Biol Phys 55 2003 688 694
16. C. Fiorino, C. Cozzarini, and V. Vavassori Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: Analysis of a large group of patients pooled from three institutions Radiother Oncol 64 2002 1 12
17. C. Greco, C. Mazzetta, and F. Cattani Finding dose-volume constraints to reduce late rectal toxicity following 3D-conformal radiotherapy (3D-CRT) of prostate cancer Radiother Oncol 69 2003 215 222
18. A. Capp, M. Inostroza-Ponta, and M. Bill Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial Radiother Oncol 90 2009 400 407
19. D.S. Lamb, D.W. Denham, and H. Marneghan Acceptability of short term neo-adjuvant deprivation in patients with locally advanced prostate cancer Radiother Oncol 68 2003 255 267
20. S.L. Gulliford, K. Foo, and R.C. Morgan Dose-volume constraints to reduce rectal side effects from prostate radiotherapy: Evidence from MRC RT01 Trial ISRCTN 47772397 Int J Radiat Oncol Biol Phys 76 2010 747 754
21. C. Fiorino, G. Sanguineti, and C. Cozzarini Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer Int J Radiat Oncol Biol Phys 57 2003 953 962
22. J. Andreyev Gastrointestinal symptoms after pelvic radiotherapy: A new understanding to improve management of symptomatic patients Lancet Oncol 8 2007 1007 1017